← Back to headlines
Big Pharma's Smaller Deals Benefit Biotech Sector
Major pharmaceutical companies are focusing on smaller deals, a strategic shift that is proving advantageous for the biotechnology sector.
13 Apr, 09:30 — 13 Apr, 09:30
Sources
Showing 1 of 1 sources
